Heart Disease News and Research

Latest Heart Disease News and Research

Cardiologists identify blood protein fragment that can predict heart attack

Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.

6 Jan 2011

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros Corporation (Nasdaq: OMER) today announced that it has obtained an exclusive license from The Regents of the University of California to a new series of antifibrinolytic agents. These optimized agents represent a significant potential advance in the control of surgical and traumatic bleeding.

6 Jan 2011

Pico-Tesla commences placebo-controlled Magneceutical Therapy study for Alzheimer's disease

Pico-Tesla, The Magneceutical Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have Alzheimer's disease symptoms.

6 Jan 2011

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

Ikaria, Inc. today announced that the U.S. Food and Drug Administration has granted INOMAX for inhalation an additional six months of marketing exclusivity, known as "pediatric exclusivity."

6 Jan 2011

Researchers investigate umbilical cord blood stem cells for traumatic brain injury in children

The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.

6 Jan 2011

Stereotaxis extends strategic partnership to distribute magnetic ablation catheters

Stereotaxis, Inc. announced today that the Company and its existing strategic catheter partner have extended their exclusive worldwide agreement for the distribution of existing approved magnetic ablation catheters through the end of 2015.

6 Jan 2011

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

The American Heart Association is participating in an international effort to prepare for a United Nations (UN) high-level summit next year on non-communicable diseases (NCDs). These diseases — mainly cardiovascular illnesses including stroke, diabetes, cancer and chronic respiratory conditions — were estimated to cause more than 60 percent of deaths worldwide in 2005.

5 Jan 2011

New laboratory manual on imaging in developmental biology

Imaging technologies have revolutionized the study of developmental biology and are now essential tools for researchers in the field. A newly released laboratory manual, Imaging in Developmental Biology, presents a comprehensive set of visualization methods specifically for developmental biologists. It is the newest volume in a series of imaging manuals published by Cold Spring Harbor Laboratory Press.

5 Jan 2011

Tablet splitting leads to inaccurate dosages

Medical experts have issued a warning about the common practice of tablet splitting, after a study found that nearly a third of the split fragments deviated from recommended dosages by 15 per cent or more.

5 Jan 2011

Predictive value of plasma galectin-3 levels in heart failure patients: Study

BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics, today announced the publication of a study exploring the predictive value of plasma galectin-3 levels in heart failure (HF) patients with reduced and preserved ejection fraction.

5 Jan 2011

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.

5 Jan 2011

Administration of therapeutic hypothermia for TBI should depend on clinical condition of individual patients

Lowering the body temperature of patients soon after they have suffered a severe brain injury may reduce neurologic complications and improve outcomes. The safety of therapeutic hypothermia for traumatic brain injury (TBI) has been demonstrated in national studies. According to a Roundtable Discussion of renowned experts in the field, when and how it is administered should depend on the clinical condition of individual patients.

5 Jan 2011

Star Scientific plans to submit new, moist-snuff product for FDA evaluation

Star Scientific Inc.'s plan to submit a new, moist-snuff product for evaluation by the Food and Drug Administration as a "modified risk" tobacco product shows the vital importance of the new law giving the FDA the authority to regulate tobacco products and any health claims used to market them.

5 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

GLUMETZA tablets are now available to wholesalers and physicians

Santarus, and Depomed, today announced that supply of GLUMETZA® 500 mg to wholesalers and retailers has resumed. GLUMETZA is a once-daily, extended release formulation of metformin and is approved for use in adults with type 2 diabetes mellitus.

5 Jan 2011

DMC announces contracts over $60M after sealing partnership with Vanguard Health Systems

Detroit Medical Center (DMC) officials today made good on their promise to get right to work on hospital construction projects, announcing contracts totaling over $60 million just four days after DMC's landmark partnership with Vanguard Health Systems was sealed.

5 Jan 2011

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Atherosclerosis is the leading cause of death in the developed world. While a number of risk factors for atherosclerosis have been defined, scientists continue to study other possible risk factors for this disease. Recent epidemiological and experimental studies link infectious agents with the development of inflammatory atherosclerosis. A hallmark of chronic infection with the oral pathogen Porphyromonas gingivalis is the induction of a chronic inflammatory response.

5 Jan 2011

Anti-tobacco laws can reduce smoking habits in Europe

The Global Alliance for Chronic Diseases has announced its intention to release a Request for Applications on Implementation Research on Hypertension in Low and Middle Income Countries.

5 Jan 2011

Anaphylatoxin C5a may be responsible for devastating effects of atherosclerosis

For decades, doctors have looked at fitness levels, weight, and overall health risk factors for heart disease and stroke. Now, they may soon add a new risk factor to the list: activation of the complement system. The complement system is usually implicated in immune responses, but now there's a role for it in cardiovascular disease.

5 Jan 2011

iHealth Lab introduces Blood Pressure Monitoring System for iPhone, iPod touch and iPad

iHealth Lab Inc., a pioneering designer and manufacturer of digital personal healthcare products, today announced the launch of the iHealth Blood Pressure Monitoring System for iPhone, iPod touch and iPad. Comprised of a hardware dock, blood pressure arm cuff and iHealth App, this breakthrough product lets users self-monitor their blood pressure from the convenience of their home, and share the results with friends, family and most importantly, their doctor.

5 Jan 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Cardiologists identify blood protein fragment that can predict heart attack

Omeros receives exclusive license for new series of antifibrinolytic agents

Pico-Tesla commences placebo-controlled Magneceutical Therapy study for Alzheimer's disease

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

Researchers investigate umbilical cord blood stem cells for traumatic brain injury in children

Stereotaxis extends strategic partnership to distribute magnetic ablation catheters

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

New laboratory manual on imaging in developmental biology

Tablet splitting leads to inaccurate dosages

Predictive value of plasma galectin-3 levels in heart failure patients: Study

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

Administration of therapeutic hypothermia for TBI should depend on clinical condition of individual patients

Star Scientific plans to submit new, moist-snuff product for FDA evaluation

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

GLUMETZA tablets are now available to wholesalers and physicians

DMC announces contracts over $60M after sealing partnership with Vanguard Health Systems

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Anti-tobacco laws can reduce smoking habits in Europe

Anaphylatoxin C5a may be responsible for devastating effects of atherosclerosis

iHealth Lab introduces Blood Pressure Monitoring System for iPhone, iPod touch and iPad

Innovation in neuroscience drug discovery - eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in